Attached files
| file | filename |
|---|---|
| EX-99.2 - EXHIBIT 99.2 - Prestige Consumer Healthcare Inc. | exhibit992prestigebrands.htm |
| 8-K - 8-K - Prestige Consumer Healthcare Inc. | a8-kpressreleaseseptember3.htm |
Exhibit 99.1
Prestige Consumer Healthcare Inc. Reports Fiscal 2019 Second Quarter Results
• | Revenue was $239.4 Million in Q2 Fiscal 2019; Organic Revenue Growth of 1.6% Excluding Household Cleaning Divestiture |
• | GAAP Diluted EPS Increased 4% to $0.59 in Q2; Adjusted EPS Increased 7% to $0.65 |
• | Reduced Debt by $100 Million From Cash Generation and Divestiture Proceeds |
• | Reaffirming Previously Issued FY’19 Outlook |
TARRYTOWN, N.Y.--(GLOBE NEWSWIRE)-November 1, 2018-- Prestige Consumer Healthcare Inc. (NYSE:PBH), formerly Prestige Brands Holdings, Inc., today reported financial results for its second quarter and six months ended September 30, 2018.
“We are pleased with second quarter results, driven by continued solid consumption trends across our diversified and leading consumer healthcare portfolio. We reduced our debt by $100 million during the quarter, continuing our prudent capital allocation strategy. Based on our results for the first six months of fiscal 2019 and expectations for the remainder of the year, we are well positioned to achieve our full-year fiscal 2019 guidance,” said Ron Lombardi, Chief Executive Officer of Prestige Consumer Healthcare.
Second Fiscal Quarter Ended September 30, 2018
Reported revenues in the second quarter of fiscal 2019 decreased 7.2% to $239.4 million, compared to $258.0 million in the second quarter of fiscal 2018. Revenues increased 1.6% on an organic basis, which excludes the impact related to the divested Household Cleaning segment. Organic revenues for the quarter were driven by continued strong consumption levels across the Company’s core brands, but were partially offset by the previously announced change in accounting policies around revenue recognition and the timing of related expenses as well as the transition of new packaging for the Company’s BC and Goody’s brands.
Reported gross profit margin in the second quarter fiscal 2019 was 57.4%, compared to 55.8% for the second quarter of fiscal 2018 or 56.3% excluding adjustments related to the Fleet acquisition and integration in the prior year. Sequentially, gross margin improved from 55.4% reported in first quarter fiscal 2019. The quarter benefited from increasingly stabilized freight and warehouse costs and the divestiture of the Household Cleaning segment. These improvements were partially offset by the expected BC and Goody’s packaging restage and the change in revenue recognition and the timing of related expenses.
Reported net income for the second quarter of fiscal 2019 totaled $30.8 million versus the prior year comparable quarter’s net income of $30.7 million. Diluted earnings per share were $0.59 for the second quarter of fiscal 2019 compared to $0.57 in the prior year comparable period. Non-GAAP adjusted net income for the second quarter of fiscal 2019 was $34.2 million, an increase over the prior year period’s adjusted net income of $32.5 million. Non-GAAP adjusted earnings per share were $0.65 per share for the second quarter of fiscal 2019 compared to $0.61 per share in the prior year comparable period.
Adjustments to net income in the second quarter of fiscal 2019 and fiscal 2018 include integration, transition, purchase accounting, legal and various other costs associated with acquisitions and divestitures, and the related income tax effects of the adjustments. Adjustments to net income in the second quarter of fiscal 2019 also include accelerated amortization of debt origination costs.
First Half of Fiscal 2019 Ended September 30, 2018
Reported revenues for the first six months of fiscal 2019 decreased 4.1% to $493.3 million compared to $514.6 million in the first six months of fiscal 2018. Revenues for the first six months of fiscal 2019 were driven by continued strong consumption levels across the Company’s legacy brands, offset by the divestiture of the non-core Household Cleaning segment in the second quarter of fiscal 2019. Organic revenue increased 0.4% for the first six months as consumption gains were partially offset by changes in accounting policies around revenue recognition and the timing of related expenses, as well as timing the transition of new packaging for the Company’s BC and Goody’s brands.
Reported gross profit margin in the first six months of fiscal 2019 was 56.4%, compared to 55.9% for the first six months of fiscal 2018 or 56.6% excluding adjustments related to the Fleet transition and integration in the prior year. The gross profit margin was in-line with the same period in the previous year as the positive impact of the divestiture of the non-core Household Cleaning segment was partially offset by the change in accounting policies around revenue recognition and the timing of related expenses as well as higher freight and warehousing costs.
Advertising and promotion expense for the first six months of fiscal 2019 was $74.2 million, or 15.0% of sales, compared to $76.1 million, or 14.8% of sales, in the prior year. As expected, higher advertising and promotion expense as a percentage of sales was attributable to ongoing investments behind the Company’s long-term brand building strategy.
Reported net income for the first six months of fiscal 2019 totaled $65.3 million versus the prior year comparable period net income of $64.5 million. Diluted earnings per share were $1.24 for the first six months of fiscal 2019 compared to $1.20 per share in the prior year comparable period. Non-GAAP adjusted net income for the first six months of fiscal 2019 was $70.0 million, an increase over the prior year period’s adjusted net income of $68.0 million. Non-GAAP adjusted earnings per share were $1.33 per share for the first six months of fiscal 2019 compared to $1.27 per share in the first six months of fiscal 2018.
Adjustments to net income in the first six months of fiscal 2019 and fiscal 2018 include integration, transition, purchase accounting, legal and various other costs associated with acquisitions and divestitures, and the related income tax effects of the adjustments. Adjustments to net income in the first six months of fiscal 2019 also include accelerated amortization of debt origination costs.
Free Cash Flow and Balance Sheet
The Company's net cash provided by operating activities for the second fiscal quarter of 2019 was $39.3 million compared to $54.4 million during the same period a year earlier. Non-GAAP adjusted free cash flow for the second fiscal quarter of 2019 was $44.1 million, compared to $54.8 million in the prior year comparable quarter. Changes in cash flow were driven by the divestiture of the Household Cleaning segment as well as an increase in inventory related to the launch of new packaging for the Company’s BC and Goody’s brands.
The Company's net debt position as of September 30, 2018 was approximately $1.9 billion. At September 30, 2018 the Company's covenant-defined leverage ratio was approximately 5.2x. The Company reduced debt by $100 million versus the first quarter fiscal 2019 through a combination of cash generation and approximately $50 million from Household Cleaning segment divestiture proceeds.
Segment Review
North American OTC Healthcare: Segment revenues totaled $216.0 million for the second quarter of fiscal 2019, compared to the prior year comparable quarter's revenues of $215.3 million. The second quarter fiscal 2019 result was favorably impacted by increased consumption among the majority of core OTC brands, but offset by the impacts of a change in accounting policies surrounding revenue recognition and the launch of new BC and Goody’s packaging.
For the first six months of the current fiscal year, reported revenues for the North American OTC segment were $430.7 million compared to $431.1 million in the prior year comparable period. The first six months of 2019 were favorably impacted by increased consumption among the majority of core OTC brands, but offset by the impacts of a change in accounting policies surrounding revenue recognition and the launch of new BC and Goody’s packaging.
International OTC Healthcare: Segment fiscal second quarter 2019 revenues totaled $23.4 million, an increase of 11.7% versus $21.0 million reported in the prior year comparable period. Higher revenues versus the prior year were driven by consumption growth and the normalization of differences in distributor orders and shipments experienced in first quarter.
For the first six months of the current fiscal year, reported revenues for the International OTC Healthcare segment were $42.8 million, an increase of 2.3% over the prior year comparable period’s revenues of $41.9 million.
Household Cleaning: As previously announced, the Company closed the sale of its Household Cleaning segment on July 2, 2018 and used net proceeds from the divestiture to pay down debt. For the first quarter of fiscal 2019, the Household Cleaning segment generated $19.8 million in revenues with no reported revenue in the second quarter of 2019.
Commentary and Outlook for Fiscal 2019
Ron Lombardi, CEO, stated, “Our solid overall second quarter and first half of fiscal 2019 performance are the result of our successful long-term brand-building and portfolio evolution efforts. In our second quarter, we delivered approximately 2% organic growth trends despite the temporary timing factors related to the change in revenue recognition and the BC & Goody’s restaged packaging. In addition, freight and warehouse costs continue to improve to more normalized levels. Meanwhile we used $100 million in the quarter from cash flow and the sale of Household Cleaning towards debt reduction. This debt reduction demonstrates our ongoing commitment to disciplined capital allocation.”
“We are reaffirming our fiscal 2019 outlook for revenue, profitability and cash flow. Our consumer healthcare platform includes a strong and diverse portfolio of brands well positioned for continued long-term growth. We remain focused on the execution of our three-pillar strategy of brand-building, maintaining a strong financial profile, and efficient capital allocation and look forward to continuing to use this approach to drive shareholder value over time,” he concluded.
Fiscal 2019 Full-Year Outlook | |
Revenue | $985 to $995 million |
Organic Growth Percentage* | 0.5% to 1.5% |
Adjusted E.P.S.* | $2.84 to $2.92 |
Adjusted Free Cash Flow* | $205 million or more |
Fiscal Q2 Conference Call, Accompanying Slide Presentation and Replay
The Company will host a conference call to review its second quarter results today, November 1, 2018 at 8:30 a.m. ET. The toll-free dial-in numbers are 844-233-9440 within North America and 574-990-1016 outside of North America. The conference ID number is 1375008. The Company provides a live Internet webcast, a slide presentation to accompany the call, as well as an archived replay, all of which can be accessed from the Investor Relations page of the Company's website at www.prestigebrands.com. The slide presentation can be accessed just before the call from the Investor Relations page of the website by clicking on Webcasts and Presentations.
Telephonic replays will be available for two weeks following the completion of the call and can be accessed at 855-859-2056 within North America and at 404-537-3406 from outside North America. The conference ID is 1375008.
Non-GAAP and Other Financial Information
In addition to financial results reported in accordance with generally accepted accounting principles (GAAP), we have provided certain non-GAAP financial information in this release to aid investors in understanding the Company's performance. Each non-GAAP financial measure is defined and reconciled to its most closely related GAAP financial measure in the “About Non-GAAP Financial Measures” section at the end of this earnings release.
Note Regarding Forward-Looking Statements
This news release contains "forward-looking statements" within the meaning of the federal securities laws that are intended to qualify for the Safe Harbor from liability established by the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" generally can be identified by the use of forward-looking terminology such as "assumptions," "target," "guidance," “strategy,” "outlook," "plans," "projection," "may," "will," "would," "expect," "intend," "estimate," "anticipate," "believe”, "potential," or "continue" (or the negative or other derivatives of each of these terms) or similar terminology. The "forward-looking statements" include, without limitation, statements regarding the Company's expectations regarding future operating results including revenues, earnings per share and free cash flow, the Company's ability to continue to improve freight and warehousing costs, the Company’s ability to increase shareholder value and the Company’s ability to position itself for long-term success and growth. These statements are based on management's estimates and assumptions with respect to future events and financial performance and are believed to be reasonable, though are inherently uncertain and difficult to predict. Actual results could differ materially from those expected as a result of a variety of factors, including the impact of the Company’s advertising and promotional and new product development initiatives, customer inventory management initiatives, general economic and business conditions, fluctuating foreign exchange rates, consumer trends, competitive pressures, and the ability of the Company’s third party manufacturers and logistics providers and suppliers to meet demand for its products and to reduce costs. A discussion of other factors that could cause results to vary is included in the Company's Annual Report on Form 10-K for the year ended March 31, 2018 and other periodic reports filed with the Securities and Exchange Commission.
About Prestige Consumer Healthcare Inc.
The Company markets and distributes brand name over-the-counter healthcare products throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® sore throat treatments, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, The Doctor's® NightGuard® dental protector, Efferdent® denture care products, Luden's® throat drops, Debrox® earwax remover,
Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigebrands.com.
* See the “About Non-GAAP Financial Measures” section of this report for further presentation information.
Prestige Consumer Healthcare Inc.
Condensed Consolidated Statements of Income and Comprehensive Income
(Unaudited)
Three Months Ended September 30, | Six Months Ended September 30, | |||||||||||||||
(In thousands, except per share data) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
Revenues | ||||||||||||||||
Net sales | $ | 239,354 | $ | 257,930 | $ | 493,308 | $ | 514,417 | ||||||||
Other revenues | 3 | 96 | 29 | 182 | ||||||||||||
Total revenues | 239,357 | 258,026 | 493,337 | 514,599 | ||||||||||||
Cost of Sales | ||||||||||||||||
Cost of sales excluding depreciation | 100,647 | 112,580 | 212,716 | 224,337 | ||||||||||||
Cost of sales depreciation | 1,238 | 1,348 | 2,526 | 2,688 | ||||||||||||
Cost of sales | 101,885 | 113,928 | 215,242 | 227,025 | ||||||||||||
Gross profit | 137,472 | 144,098 | 278,095 | 287,574 | ||||||||||||
Operating Expenses | ||||||||||||||||
Advertising and promotion | 37,042 | 39,188 | 74,153 | 76,132 | ||||||||||||
General and administrative | 24,034 | 21,999 | 47,975 | 42,409 | ||||||||||||
Depreciation and amortization | 6,756 | 7,186 | 13,840 | 14,353 | ||||||||||||
Gain on divestiture | (1,284 | ) | — | (1,284 | ) | — | ||||||||||
Total operating expenses | 66,548 | 68,373 | 134,684 | 132,894 | ||||||||||||
Operating income | 70,924 | 75,725 | 143,411 | 154,680 | ||||||||||||
Other (income) expense | ||||||||||||||||
Interest income | (33 | ) | (85 | ) | (133 | ) | (154 | ) | ||||||||
Interest expense | 27,103 | 26,921 | 53,143 | 53,331 | ||||||||||||
Other expense (income), net | 335 | (432 | ) | 422 | (506 | ) | ||||||||||
Total other expense | 27,405 | 26,404 | 53,432 | 52,671 | ||||||||||||
Income before income taxes | 43,519 | 49,321 | 89,979 | 102,009 | ||||||||||||
Provision for income taxes | 12,678 | 18,616 | 24,672 | 37,545 | ||||||||||||
Net income | $ | 30,841 | $ | 30,705 | $ | 65,307 | $ | 64,464 | ||||||||
Earnings per share: | ||||||||||||||||
Basic | $ | 0.59 | $ | 0.58 | $ | 1.25 | $ | 1.21 | ||||||||
Diluted | $ | 0.59 | $ | 0.57 | $ | 1.24 | $ | 1.20 | ||||||||
Weighted average shares outstanding: | ||||||||||||||||
Basic | 51,841 | 53,098 | 52,238 | 53,068 | ||||||||||||
Diluted | 52,153 | 53,539 | 52,545 | 53,524 | ||||||||||||
Comprehensive income, net of tax: | ||||||||||||||||
Currency translation adjustments | (2,145 | ) | 2,716 | (5,119 | ) | 3,835 | ||||||||||
Unrecognized net gain on pension plans | — | — | — | 1 | ||||||||||||
Total other comprehensive (loss) income | (2,145 | ) | 2,716 | (5,119 | ) | 3,836 | ||||||||||
Comprehensive income | $ | 28,696 | $ | 33,421 | $ | 60,188 | $ | 68,300 | ||||||||
Prestige Consumer Healthcare Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
(In thousands) | September 30, 2018 | March 31, 2018 | |||||
Assets | |||||||
Current assets | |||||||
Cash and cash equivalents | $ | 36,910 | $ | 32,548 | |||
Accounts receivable, net of allowance of $14,433 and $12,734, respectively | 153,849 | 140,881 | |||||
Inventories | 113,569 | 118,547 | |||||
Deferred income tax assets | — | 26 | |||||
Prepaid expenses and other current assets | 10,172 | 11,475 | |||||
Total current assets | 314,500 | 303,477 | |||||
Property, plant and equipment, net | 52,321 | 52,552 | |||||
Goodwill | 612,444 | 620,098 | |||||
Intangible assets, net | 2,715,070 | 2,780,916 | |||||
Other long-term assets | 3,360 | 3,569 | |||||
Total Assets | $ | 3,697,695 | $ | 3,760,612 | |||
Liabilities and Stockholders' Equity | |||||||
Current liabilities | |||||||
Accounts payable | $ | 66,251 | $ | 61,390 | |||
Accrued interest payable | 9,665 | 9,708 | |||||
Other accrued liabilities | 70,057 | 52,101 | |||||
Total current liabilities | 145,973 | 123,199 | |||||
Long-term debt, net | 1,895,835 | 1,992,952 | |||||
Deferred income tax liabilities | 440,853 | 442,518 | |||||
Other long-term liabilities | 21,796 | 23,333 | |||||
Total Liabilities | 2,504,457 | 2,582,002 | |||||
Stockholders' Equity | |||||||
Preferred stock - $0.01 par value | |||||||
Authorized - 5,000 shares | |||||||
Issued and outstanding - None | — | — | |||||
Common stock - $0.01 par value | |||||||
Authorized - 250,000 shares | |||||||
Issued - 53,609 shares at September 30, 2018 and 53,396 shares at March 31, 2018 | 536 | 534 | |||||
Additional paid-in capital | 474,137 | 468,783 | |||||
Treasury stock, at cost - 1,871 shares at September 30, 2018 and 353 shares at March 31, 2018 | (59,928 | ) | (7,669 | ) | |||
Accumulated other comprehensive loss, net of tax | (24,434 | ) | (19,315 | ) | |||
Retained earnings | 802,927 | 736,277 | |||||
Total Stockholders' Equity | 1,193,238 | 1,178,610 | |||||
Total Liabilities and Stockholders' Equity | $ | 3,697,695 | $ | 3,760,612 | |||
Prestige Consumer Healthcare Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
Six Months Ended September 30, | |||||||
(In thousands) | 2018 | 2017 | |||||
Operating Activities | |||||||
Net income | $ | 65,307 | $ | 64,464 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation and amortization | 16,366 | 17,041 | |||||
Gain on divestiture | (1,284 | ) | — | ||||
Loss on disposal of property and equipment | 37 | 1,461 | |||||
Deferred income taxes | 339 | 16,321 | |||||
Amortization of debt origination costs | 3,021 | 3,494 | |||||
Excess tax benefits from share-based awards | — | 470 | |||||
Stock-based compensation costs | 4,328 | 4,726 | |||||
Other | 247 | — | |||||
Changes in operating assets and liabilities: | |||||||
Accounts receivable | (7,718 | ) | (9,345 | ) | |||
Inventories | (4,145 | ) | (3,409 | ) | |||
Prepaid expenses and other current assets | 1,302 | 17,123 | |||||
Accounts payable | 4,187 | 8,008 | |||||
Accrued liabilities | 14,339 | (11,869 | ) | ||||
Other | (1,219 | ) | 55 | ||||
Net cash provided by operating activities | 95,107 | 108,540 | |||||
Investing Activities | |||||||
Purchases of property, plant and equipment | (5,074 | ) | (4,785 | ) | |||
Acquisition of Fleet escrow receipt | — | 970 | |||||
Proceeds from divestiture | 65,912 | — | |||||
Net cash provided by (used in) investing activities | 60,838 | (3,815 | ) | ||||
Financing Activities | |||||||
Term loan repayments | (100,000 | ) | (105,000 | ) | |||
Borrowings under revolving credit agreement | 30,000 | — | |||||
Repayments under revolving credit agreement | (30,000 | ) | — | ||||
Proceeds from exercise of stock options | 1,028 | 1,466 | |||||
Fair value of shares surrendered as payment of tax withholding | (2,281 | ) | (1,075 | ) | |||
Repurchase of common stock | (49,978 | ) | — | ||||
Net cash used in financing activities | (151,231 | ) | (104,609 | ) | |||
Effects of exchange rate changes on cash and cash equivalents | (352 | ) | 1,006 | ||||
Increase in cash and cash equivalents | 4,362 | 1,122 | |||||
Cash and cash equivalents - beginning of period | 32,548 | 41,855 | |||||
Cash and cash equivalents - end of period | $ | 36,910 | $ | 42,977 | |||
Interest paid | $ | 49,147 | $ | 49,404 | |||
Income taxes paid | $ | 2,444 | $ | 9,037 | |||
Prestige Consumer Healthcare Inc.
Condensed Consolidated Statements of Income
Business Segments
(Unaudited)
Three Months Ended September 30, 2018 | |||||||||||||||
(In thousands) | North American OTC Healthcare | International OTC Healthcare | Household Cleaning | Consolidated | |||||||||||
Total segment revenues* | $ | 215,950 | $ | 23,407 | $ | — | $ | 239,357 | |||||||
Cost of sales | 92,007 | 9,878 | — | 101,885 | |||||||||||
Gross profit | 123,943 | 13,529 | — | 137,472 | |||||||||||
Advertising and promotion | 33,325 | 3,717 | — | 37,042 | |||||||||||
Contribution margin | $ | 90,618 | $ | 9,812 | $ | — | 100,430 | ||||||||
Other operating expenses | 29,506 | ||||||||||||||
Operating income | 70,924 | ||||||||||||||
Other expense | 27,405 | ||||||||||||||
Income before income taxes | 43,519 | ||||||||||||||
Provision for income taxes | 12,678 | ||||||||||||||
Net income | $ | 30,841 | |||||||||||||
* Intersegment revenues of $1.6 million were eliminated from the North American OTC Healthcare segment.
Six Months Ended September 30, 2018 | |||||||||||||||
(In thousands) | North American OTC Healthcare | International OTC Healthcare | Household Cleaning | Consolidated | |||||||||||
Total segment revenues* | $ | 430,725 | $ | 42,801 | $ | 19,811 | $ | 493,337 | |||||||
Cost of sales | 181,160 | 17,494 | 16,588 | 215,242 | |||||||||||
Gross profit | 249,565 | 25,307 | 3,223 | 278,095 | |||||||||||
Advertising and promotion | 66,583 | 7,140 | 430 | 74,153 | |||||||||||
Contribution margin | $ | 182,982 | $ | 18,167 | $ | 2,793 | 203,942 | ||||||||
Other operating expenses | 60,531 | ||||||||||||||
Operating income | 143,411 | ||||||||||||||
Other expense | 53,432 | ||||||||||||||
Income before income taxes | 89,979 | ||||||||||||||
Provision for income taxes | 24,672 | ||||||||||||||
Net income | $ | 65,307 | |||||||||||||
*Intersegment revenues of $4.3 million were eliminated from the North American OTC Healthcare segment.
Three Months Ended September 30, 2017 | |||||||||||||||
(In thousands) | North American OTC Healthcare | International OTC Healthcare | Household Cleaning | Consolidated | |||||||||||
Total segment revenues* | $ | 215,302 | $ | 20,957 | $ | 21,767 | $ | 258,026 | |||||||
Cost of sales | 87,184 | 9,296 | 17,448 | 113,928 | |||||||||||
Gross profit | 128,118 | 11,661 | 4,319 | 144,098 | |||||||||||
Advertising and promotion | 35,064 | 3,593 | 531 | 39,188 | |||||||||||
Contribution margin | $ | 93,054 | $ | 8,068 | $ | 3,788 | 104,910 | ||||||||
Other operating expenses | 29,185 | ||||||||||||||
Operating income | 75,725 | ||||||||||||||
Other expense | 26,404 | ||||||||||||||
Income before income taxes | 49,321 | ||||||||||||||
Provision for income taxes | 18,616 | ||||||||||||||
Net income | $ | 30,705 | |||||||||||||
* Intersegment revenues of $2.3 million were eliminated from the North American OTC Healthcare segment.
Six Months Ended September 30, 2017 | |||||||||||||||
(In thousands) | North American OTC Healthcare | International OTC Healthcare | Household Cleaning | Consolidated | |||||||||||
Total segment revenues* | $ | 431,117 | $ | 41,855 | $ | 41,627 | $ | 514,599 | |||||||
Cost of sales | 173,685 | 19,246 | 34,094 | 227,025 | |||||||||||
Gross profit | 257,432 | 22,609 | 7,533 | 287,574 | |||||||||||
Advertising and promotion | 67,872 | 7,283 | 977 | 76,132 | |||||||||||
Contribution margin | $ | 189,560 | $ | 15,326 | $ | 6,556 | 211,442 | ||||||||
Other operating expenses | 56,762 | ||||||||||||||
Operating income | 154,680 | ||||||||||||||
Other expense | 52,671 | ||||||||||||||
Income before income taxes | 102,009 | ||||||||||||||
Provision for income taxes | 37,545 | ||||||||||||||
Net income | $ | 64,464 | |||||||||||||
* Intersegment revenues of $3.7 million were eliminated from the North American OTC Healthcare segment.
About Non-GAAP Financial Measures
In addition to financial results reported in accordance with GAAP, we disclose certain Non-GAAP financial measures ("NGFMs"), including, but not limited to, Non-GAAP Organic Revenues, Non-GAAP Organic Revenue Growth Percentage, Non-GAAP Adjusted Gross Margin, Non-GAAP Adjusted Gross Margin Percentage, Non-GAAP Adjusted Advertising and Promotion Expense, Non-GAAP Adjusted Advertising and Promotion Expense Percentage, Non-GAAP Adjusted General and Administrative Expense, Non-GAAP Adjusted General and Administrative Expense Percentage, Non-GAAP EBITDA, Non-GAAP EBITDA Margin, Non-GAAP Adjusted EBITDA, Non-GAAP Adjusted EBITDA Margin, Non-GAAP Adjusted Net Income, Non-GAAP Adjusted EPS, Non-GAAP Free Cash Flow, Non-GAAP Adjusted Free Cash Flow and Net Debt. We use these NGFMs internally, along with GAAP information, in evaluating our operating performance and in making financial and operational decisions. We believe that the presentation of these NGFMs provides investors with greater transparency, and provides a more complete understanding of our business than could be obtained absent these disclosures, because the supplemental data relating to our financial condition and results of operations provides additional ways to view our operation when considered with both our GAAP results and the reconciliations below. In addition, we believe that the presentation of each of these NGFMs is useful to investors for period-to-period comparisons of results in assessing shareholder value, and we use these NGFMs internally to evaluate the performance of our personnel and also to evaluate our operating performance and compare our performance to that of our competitors.
These NGFMs are not in accordance with GAAP, should not be considered as a measure of profitability or liquidity, and may not be directly comparable to similarly titled NGFMs reported by other companies. These NGFMs have limitations and they should not be considered in isolation from or as an alternative to their most closely related GAAP measures reconciled below. Investors should not rely on any single financial measure when evaluating our business. We recommend investors review the GAAP financial measures included in this earnings release. When viewed in conjunction with our GAAP results and the reconciliations below, we believe these NGFMs provide greater transparency and a more complete understanding of factors affecting our business than GAAP measures alone.
NGFMs Defined
We define our NGFMs presented herein as follows:
• | Non-GAAP Organic Revenues: GAAP Total Revenues excluding revenues associated with divestiture and allocated cost that remain after divestiture in the periods presented. |
• | Non-GAAP Organic Revenue Growth Percentage: Calculated as the change in Non-GAAP Organic Revenues from prior year divided by prior year Non-GAAP Organic Revenues. |
• | Non-GAAP Adjusted Gross Margin: GAAP Gross Profit minus certain integration, transition, acquisition and divestiture-related costs. |
• | Non-GAAP Adjusted Gross Margin Percentage: Calculated as Non-GAAP Adjusted Gross Margin divided by GAAP Total Revenues. |
• | Non-GAAP Adjusted Advertising and Promotion Expense: GAAP Advertising and Promotion expenses minus certain integration, transition, and acquisition-related costs. |
• | Non-GAAP Adjusted Advertising and Promotion Expense Percentage: Calculated as Non-GAAP Adjusted Advertising and Promotion expense divided by GAAP Total Revenues. |
• | Non-GAAP Adjusted General and Administrative Expense: GAAP General and Administrative expenses minus certain integration, transition, acquisition and divestiture-related costs. |
• | Non-GAAP Adjusted General and Administrative Expense Percentage: Calculated as Non-GAAP Adjusted General and Administrative expense divided by GAAP Total Revenues. |
• | Non-GAAP EBITDA: GAAP Net Income (Loss) less net interest expense (income), income taxes provision (benefit), and depreciation and amortization. |
• | Non-GAAP EBITDA Margin: Calculated as Non-GAAP EBITDA divided by GAAP Total Revenues. |
• | Non-GAAP Adjusted EBITDA: Non-GAAP EBITDA less certain integration, transition, acquisition and divestiture-related costs and gain on divestiture. |
• | Non-GAAP Adjusted EBITDA Margin: Calculated as Non-GAAP Adjusted EBITDA divided by GAAP Total Revenues. |
• | Non-GAAP Adjusted Net Income: GAAP Net Income (Loss) before certain integration, transition, acquisition and divestiture-related costs, gain on divestiture, accelerated amortization of debt origination costs, applicable tax impact associated with these items and normalized tax rate adjustment. |
• | Non-GAAP Adjusted EPS: Calculated as Non-GAAP Adjusted Net Income, divided by the weighted average number of common and potential common shares outstanding during the period. |
• | Non-GAAP Free Cash Flow: GAAP Net cash provided by operating activities less cash paid for capital expenditures. |
• | Non-GAAP Adjusted Free Cash Flow: Non-GAAP Free Cash Flow plus cash payments made for integration and transition costs associated with acquisition and divestiture. |
• | Net Debt: Calculated as total principal amount of debt outstanding ($1,913,000 at September 30, 2018) less cash and cash equivalents ($36,910 at September 30, 2018). Amounts in thousands. |
The following tables set forth the reconciliations of each of our NGFMs to their most directly comparable financial measures presented in accordance with GAAP.
Reconciliation of GAAP Total Revenues to Non-GAAP Organic Revenues and related Non-GAAP Organic Revenue Growth percentage:
Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
(In thousands) | |||||||||||||||
GAAP Total Revenues | $ | 239,357 | $ | 258,026 | $ | 493,337 | $ | 514,599 | |||||||
Revenue Growth | (7.2 | )% | (4.1 | )% | |||||||||||
Adjustments: | |||||||||||||||
Revenues associated with divestiture | — | (21,767 | ) | (19,811 | ) | (41,627 | ) | ||||||||
Allocated costs that remain after divestiture | — | (700 | ) | — | (1,400 | ) | |||||||||
Total adjustments | — | (22,467 | ) | (19,811 | ) | (43,027 | ) | ||||||||
Non-GAAP Organic Revenues | $239,357 | $ | 235,559 | $ | 473,526 | $ | 471,572 | ||||||||
Non-GAAP Organic Revenue Growth | 1.6 | % | 0.4 | % | |||||||||||
Reconciliation of GAAP Gross Profit to Non-GAAP Adjusted Gross Margin and related Non-GAAP Adjusted Gross Margin percentage:
Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
(In thousands) | |||||||||||||||
GAAP Total Revenues | $ | 239,357 | $ | 258,026 | $ | 493,337 | $ | 514,599 | |||||||
GAAP Gross Profit | $ | 137,472 | $ | 144,098 | $ | 278,095 | $ | 287,574 | |||||||
GAAP Gross Profit as a Percentage of GAAP Total Revenue | 57.4 | % | 55.8 | % | 56.4 | % | 55.9 | % | |||||||
Adjustments: | |||||||||||||||
Integration, transition and other costs associated with divestiture and acquisition (1) | — | 1,143 | 170 | 3,719 | |||||||||||
Total adjustments | — | 1,143 | 170 | 3,719 | |||||||||||
Non-GAAP Adjusted Gross Margin | $ | 137,472 | $ | 145,241 | $ | 278,265 | $ | 291,293 | |||||||
Non-GAAP Adjusted Gross Margin as a Percentage of GAAP Total Revenues | 57.4 | % | 56.3 | % | 56.4 | % | 56.6 | % | |||||||
(1) Items related to divestiture and acquisition represent costs related to divesting of assets sold and integrating recently acquired business, including (but not limited to) costs to exit or convert contractual obligations, severance, information system conversion and consulting costs.
Reconciliation of GAAP Advertising and Promotion Expense and related GAAP Advertising and Promotion Expense percentage to Non-GAAP Adjusted Advertising and Promotion Expense and related Non-GAAP Adjusted Advertising and Promotion Expense percentage:
Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
(In thousands) | |||||||||||||||
GAAP Advertising and Promotion Expense | $ | 37,042 | $ | 39,188 | $ | 74,153 | $ | 76,132 | |||||||
GAAP Advertising and Promotion Expense as a Percentage of GAAP Total Revenue | 15.5 | % | 15.2 | % | 15.0 | % | 14.8 | % | |||||||
Adjustments: | |||||||||||||||
Integration, transition and other costs associated with acquisition(1) | — | (231 | ) | — | (192 | ) | |||||||||
Total adjustments | — | (231 | ) | — | (192 | ) | |||||||||
Non-GAAP Adjusted Advertising and Promotion Expense | $ | 37,042 | $ | 39,419 | $ | 74,153 | $ | 76,324 | |||||||
Non-GAAP Adjusted Advertising and Promotion Expense as a Percentage of GAAP Total Revenues | 15.5 | % | 15.3 | % | 15.0 | % | 14.8 | % | |||||||
Reconciliation of GAAP General and Administrative Expense and related GAAP General and Administrative Expense percentage to Non-GAAP Adjusted General and Administrative Expense and related Non-GAAP Adjusted General and Administrative Expense percentage:
Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
(In thousands) | |||||||||||||||
GAAP General and Administrative Expense(1) | $ | 24,034 | $ | 21,999 | $ | 47,975 | $ | 42,409 | |||||||
GAAP General and Administrative Expense as a Percentage of GAAP Total Revenue | 10.0 | % | 8.5 | % | 9.7 | % | 8.2 | % | |||||||
Adjustments: | |||||||||||||||
Integration, transition and other costs associated with divestiture and acquisition (2) | 2,850 | 888 | 4,272 | 1,472 | |||||||||||
Total adjustments | 2,850 | 888 | 4,272 | 1,472 | |||||||||||
Non-GAAP Adjusted General and Administrative Expense | $ | 21,184 | $ | 21,111 | $ | 43,703 | $ | 40,937 | |||||||
Non-GAAP Adjusted General and Administrative Expense Percentage as a Percentage of GAAP Total Revenues | 8.9 | % | 8.2 | % | 8.9 | % | 8.0 | % | |||||||
(1) Certain immaterial amounts have been reclassified out of general and administrative expense into other expense for 2017.
(2) Items related to divestiture and acquisition represent costs related to divesting of assets sold and integrating recently acquired business including (but not limited to), costs to exit or convert contractual obligations, severance, information system conversion and consulting costs; and certain costs related to the consummation of the acquisition and divestiture processes such as insurance costs, legal and other acquisition related professional fees.
Reconciliation of GAAP Net Income to Non-GAAP EBITDA and related Non-GAAP EBITDA Margin, Non-GAAP Adjusted EBITDA and related Non-GAAP Adjusted EBITDA Margin:
Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
(In thousands) | |||||||||||||||
GAAP Net Income | $ | 30,841 | $ | 30,705 | $ | 65,307 | $ | 64,464 | |||||||
Interest expense, net | 27,070 | 26,836 | 53,010 | 53,177 | |||||||||||
Provision for income taxes | 12,678 | 18,616 | 24,672 | 37,545 | |||||||||||
Depreciation and amortization | 7,994 | 8,534 | 16,366 | 17,041 | |||||||||||
Non-GAAP EBITDA | 78,583 | 84,691 | 159,355 | 172,227 | |||||||||||
Non-GAAP EBITDA Margin | 32.8 | % | 32.8 | % | 32.3 | % | 33.5 | % | |||||||
Adjustments: | |||||||||||||||
Integration, transition and other costs associated with divestiture and acquisition in Cost of Goods Sold (1) | — | 1,143 | 170 | 3,719 | |||||||||||
Integration, transition and other costs associated with acquisition in Advertising and Promotion Expense(1) | — | (231 | ) | — | (192 | ) | |||||||||
Integration, transition and other costs associated with divestiture and acquisition in General and Administrative Expense (1) | 2,850 | 888 | 4,272 | 1,472 | |||||||||||
Gain on divestiture | (1,284 | ) | — | (1,284 | ) | — | |||||||||
Total adjustments | 1,566 | 1,800 | 3,158 | 4,999 | |||||||||||
Non-GAAP Adjusted EBITDA | $ | 80,149 | $ | 86,491 | $ | 162,513 | $ | 177,226 | |||||||
Non-GAAP Adjusted EBITDA Margin | 33.5 | % | 33.5 | % | 32.9 | % | 34.4 | % | |||||||
(1) Items related to divestiture and acquisition represent costs related to divesting of assets sold and integrating recently acquired business including (but not limited to), costs to exit or convert contractual obligations, severance, information system conversion and consulting costs; and certain costs related to the consummation of the acquisition and divestiture processes such as insurance costs, legal and other acquisition related professional fees.
Reconciliation of GAAP Net Income to Non-GAAP Adjusted Net Income and related Non-GAAP Adjusted Earnings Per Share:
Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||||||||||||||||
2018 | 2018 Adjusted EPS | 2017 | 2017 Adjusted EPS | 2018 | 2018 Adjusted EPS | 2017 | 2017 Adjusted EPS | ||||||||||||||||||||
(In thousands, except per share data) | |||||||||||||||||||||||||||
GAAP Net Income | $ | 30,841 | $ | 0.59 | $ | 30,705 | $ | 0.57 | $ | 65,307 | $ | 1.24 | $ | 64,464 | $ | 1.20 | |||||||||||
Adjustments: | |||||||||||||||||||||||||||
Integration, transition and other costs associated with divestiture and acquisition in Cost of Goods Sold (1) | — | — | 1,143 | 0.02 | 170 | — | 3,719 | 0.07 | |||||||||||||||||||
Integration, transition and other costs associated with acquisition in Advertising and Promotion Expense(1) | — | — | (231 | ) | — | — | — | (192 | ) | — | |||||||||||||||||
Integration, transition and other costs associated with divestiture and acquisition in General and Administrative Expense (1) | 2,850 | 0.05 | 888 | 0.02 | 4,272 | 0.08 | 1,472 | 0.03 | |||||||||||||||||||
Gain on divestiture | (1,284 | ) | (0.02 | ) | — | — | (1,284 | ) | (0.02 | ) | — | — | |||||||||||||||
Accelerated amortization of debt origination costs | 706 | 0.01 | — | — | 706 | 0.01 | — | — | |||||||||||||||||||
Tax impact of adjustments (2) | 824 | 0.02 | (658 | ) | (0.01 | ) | 420 | 0.01 | (1,825 | ) | (0.03 | ) | |||||||||||||||
Normalized tax rate adjustment (3) | 222 | — | 614 | 0.01 | 415 | 0.01 | 312 | — | |||||||||||||||||||
Total adjustments | 3,318 | 0.06 | 1,756 | 0.04 | 4,699 | 0.09 | 3,486 | 0.07 | |||||||||||||||||||
Non-GAAP Adjusted Net Income and Adjusted EPS | $ | 34,159 | $ | 0.65 | $ | 32,461 | $ | 0.61 | $ | 70,006 | $ | 1.33 | $ | 67,950 | $ | 1.27 | |||||||||||
(1) Items related to divestiture and acquisition represent costs related to divesting of assets sold and integrating recently acquired business including (but not limited to), costs to exit or convert contractual obligations, severance, information system conversion and consulting costs; and certain costs related to the consummation of the acquisition and divestiture processes such as insurance costs, legal and other acquisition related professional fees.
(2) The income tax adjustments are determined using applicable rates in the taxing jurisdictions in which the above adjustments relate and includes both current and deferred income tax expense (benefit) based on the specific nature of the specific Non-GAAP performance measure.
(3) Income tax adjustment to adjust for discrete income tax items.
Reconciliation of GAAP Net Income to Non-GAAP Free Cash Flow and Non-GAAP Adjusted Free Cash Flow:
Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
(In thousands) | |||||||||||||||
GAAP Net Income | $ | 30,841 | $ | 30,705 | $ | 65,307 | $ | 64,464 | |||||||
Adjustments: | |||||||||||||||
Adjustments to reconcile net income to net cash provided by operating activities as shown in the Statement of Cash Flows | 5,349 | 21,530 | 23,054 | 43,513 | |||||||||||
Changes in operating assets and liabilities as shown in the Statement of Cash Flows | 3,065 | 2,184 | 6,746 | 563 | |||||||||||
Total adjustments | 8,414 | 23,714 | 29,800 | 44,076 | |||||||||||
GAAP Net cash provided by operating activities | 39,255 | 54,419 | 95,107 | 108,540 | |||||||||||
Purchases of property and equipment | (2,605 | ) | (2,231 | ) | (5,074 | ) | (4,785 | ) | |||||||
Non-GAAP Free Cash Flow | 36,650 | 52,188 | 90,033 | 103,755 | |||||||||||
Integration, transition and other payments associated with divestiture and acquisition (1) | 7,429 | 2,654 | 7,618 | 7,602 | |||||||||||
Non-GAAP Adjusted Free Cash Flow | $ | 44,079 | $ | 54,842 | $ | 97,651 | $ | 111,357 | |||||||
(1) Payments related to divestiture and acquisition represent costs related to divesting of assets sold and integrating recently acquired business including (but not limited to), costs to exit or convert contractual obligations, severance, information system conversion and consulting costs; and certain costs related to the consummation of the acquisition and divestiture processes such as insurance costs, legal and other acquisition related professional fees.
Outlook for Fiscal Year 2019:
Reconciliation of Projected GAAP EPS to Projected Non-GAAP Adjusted EPS:
2019 Projected EPS | |||||||
Low | High | ||||||
Projected FY'19 GAAP EPS | $ | 2.75 | $ | 2.83 | |||
Adjustments: | |||||||
Sale of Household Cleaning business (1) | 0.07 | 0.07 | |||||
Tax adjustment | 0.02 | 0.02 | |||||
Total Adjustments | 0.09 | 0.09 | |||||
Projected Non-GAAP Adjusted EPS | $ | 2.84 | $ | 2.92 | |||
(1) Represents costs related to the sale of our Household Cleaning business including (but not limited to) costs to exit or convert contractual obligations, severance, consulting costs and certain costs related to the consummation of the divestiture process such as legal and other divestiture related professional fees, net of taxes, partly offset by the gain on sale of our Household Cleaning business.
Reconciliation of Projected GAAP Net cash provided by operating activities to Projected Non-GAAP Adjusted Free Cash Flow:
2019 Projected Free Cash Flow | |||
(In millions) | |||
Projected FY'19 GAAP Net cash provided by operating activities | $ | 195 | |
Additions to property and equipment for cash | (13 | ) | |
Projected Non-GAAP Free Cash Flow | 182 | ||
Payments associated with divestiture(1) | 23 | ||
Projected Non-GAAP Adjusted Free Cash Flow | $ | 205 | |
(1) Divestiture related items represent costs related to divesting of business sold including (but not limited to) taxes, costs to exit or convert contractual obligations, severance, consulting costs and certain costs related to the consummation of the divestiture process such as legal and other divestiture related professional fees.